Veterinary News and Research

RSS

AccentHealth buys Caervision's Asthma and Allergy waiting room television network

AccentHealth, the leading patient education company at the Point-of-Care, announced today it has purchased the Asthma and Allergy waiting room television network of Caervision Corp. The new doctor office locations will become part of the AccentHealth network and will carry AccentHealth's award-winning health education programming produced by CNN.

9 Jan 2014

PET imaging of brain reveals ketamine may act as antidepressant by regulating serotonin activity

Ketamine is a potent anesthetic employed in human and veterinary medicine, and sometimes used illegally as a recreational drug. The drug is also a promising candidate for the fast treatment of depression in patients who do not respond to other medications.

7 Jan 2014

Aratana Therapeutics announces acquisition of Okapi Sciences NV

Aratana Therapeutics, Inc., a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, today announced that it has acquired Okapi Sciences NV, a Belgium-based company with a proprietary pet therapeutics antiviral platform and five clinical/development stage candidates for treating important viral diseases.

6 Jan 2014

Neogen acquires the stock of Chem-Tech

Neogen Corporation announced today that it has acquired the stock of Chem-Tech Ltd., a manufacturer of insecticides for the animal and food industries. The 35-year-old company, which is wholly owned by Pat and Kelle Rolfes, operates an extensive manufacturing and distribution facility in Pleasantville, Iowa.

2 Jan 2014

Viewpoints: Impact of 'meddling with' health law; antibiotics on farms; 'Let thirtysomethings' join Medicare

[A]ll of these last-minute policy shifts confuse people who were already struggling to understand a complex new system, ... The cumulative effect is that at least some people - we hope not many - will misunderstand their responsibilities under the law or be deterred from seeking coverage. The biggest danger is that the Obama administration is encouraging politicians to meddle in the health-care system every time a few vocal constituents get upset about its requirements (12/21).

24 Dec 2013

Researchers receive Doris Duke Foundation award to predict sickle cell crisis, monitor treatments

Researchers at Case Western Reserve University have received a $486,000 Doris Duke Foundation award to discover how to predict when sickle cell disease patients will suffer an acute crisis and monitor the effectiveness of treatments.

20 Dec 2013

Researchers produce first definitive evidence that MERS-CoV infects camels

Scientists from the Netherlands and Qatar have produced the first definitive evidence that Middle East respiratory syndrome coronavirus infects camels. The researchers used gene-sequencing techniques to show that three camels from a site where two humans contracted MERS-CoV were infected with the virus.

18 Dec 2013

Pregnant women, infants should avoid unpasteurized milk products, urge pediatricians

Pregnant women, infants and young children should avoid raw or unpasteurized milk and milk products and only consume pasteurized products, according to a new policy statement from the American Academy of Pediatrics.

16 Dec 2013

Climate change may lead to decline in snail fever

The dangerous parasite Schistosoma mansoni that causes snail fever in humans could become significantly less common in the future a new international study led by researchers from the University of Copenhagen predicts. The results are surprising because they contradict the general assumption that climate change leads to greater geographical spread of diseases. The explanation is that the parasite's host snails stand to lose suitable habitat due to climate change.

13 Dec 2013

Researchers discover completely new targets for treatment of blood cancers

A particularly aggressive form of leukemia is the acute lymphoblastic leukemia (ALL). It is especially common among children and very difficult to treat. Researchers from the University of Veterinary Medicine, Vienna have now discovered completely new targets for the treatment of blood cancers.

13 Dec 2013

Researchers discover easy-to-use method for bonding gels and biological tissues

Researchers have discovered an efficient and easy-to-use method for bonding together gels and biological tissues. A team headed by Ludwik Leibler, involving researchers from the Laboratoire Matière Molle et Chimie (CNRS/ESPCI ParisTech) and the Laboratoire Physico-Chimie des Polymères et Milieux Dispersés (CNRS/ UPMC/ESPCI ParisTech), has succeeded in obtaining very strong adhesion between two gels by spreading on their surface a solution containing nanoparticles.

12 Dec 2013

Research: Creuztfeldt-Jakob disease might be transmitted by blood transfusion

Creuztfeldt-Jakob disease (CJD) is a rare but fatal disease in humans. For the first time, the presence of infectivity[1] in the blood of patients affected by sporadic and the new variant of CJD was established by scientists from the French National Institute for Agricultural Research (INRA) and the French National Veterinary School (ENVT), in collaboration with European partners.

12 Dec 2013

Study reveals pathogenic factor that triggers prion and neurodegenerative diseases

Transmissible spongiform encephalopathy or prion disease is triggered by the conversion from cellular prion protein to pathogenic prion protein.

12 Dec 2013

MAXIMUS Foundation Chairman wins 2013 Ripple of Hope Award for contributions in health care programs

MAXIMUS, a leading provider of government services worldwide, announced today that Dr. John F. Boyer, Chairman of the MAXIMUS Foundation and Chairman of MAXIMUS Federal Services, will receive a 2013 Ripple of Hope Award from the Robert F. Kennedy Center for Justice and Human Rights, tonight, December 11, at the New York Hilton in Manhattan.

11 Dec 2013

New genetics promises to change faulty genes of future generations by using "designer sperm”

Bethesda, MD-Get ready: The "new genetics" promises to change faulty genes of future generations by introducing new, functioning genes using "designer sperm." A new research report appearing online in The FASEB Journal, shows that introducing new genetic material via a viral vector into the sperm of mice leads to the presence and activity of those genes in the resulting embryos.

3 Dec 2013

Research: Modification of SUMO protein plays vital role in normal brain function

Scientists are a step closer to understanding how some of the brain's 100 billion nerve cells co-ordinate their communication.

28 Nov 2013

Rapid DNA biochip tests for screening disease-causing bacteria

Patients affected by a bacterial infection can usually be treated with an antibiotic. But sometimes a resistant bacterial strain is causing the infection. In a hospital setting, doctors ideally want to know if they are dealing with such bacteria and which drugs they should choose. But if the doctor runs a test it can take days to get a result. Now, a European project is paving the way for much more rapid tests using DNA biochips. The aim is to rapidly screen disease-causing bacteria using a microarray to spot which resistant genes are present in bacteria.

20 Nov 2013

UCP1 protein helps fight against obesity

The uncoupling Protein 1 (UCP1) is found exclusively in brown adipose tissue. Until some years ago it was thought that only babies and hibernating animals had brown adipose tissue, but since then it also has been found in adults, so UCP1 could be useful in the fight against obesity.

20 Nov 2013

Manipulating PRH protein can help prevent cancer cells from unnecessary migration

Understanding how and why cancer cells move away from their original location is important to find ways to stop the spread of the disease. New findings, published in the Nature journal Oncogene, reveal how a protein, called 'PRH', is normally able to prevent cells from unnecessary migration. It is likely that this protein is less effective in cancer cells allowing the cells to venture away.

19 Nov 2013

Research could refine next generation of drugs to help treat dementia

A £1.1 million grant to understand how one of the brain's key neurotransmitters called 'acetylcholine' influences brain activity has been awarded to University of Bristol researchers. The Wellcome Trust award will help scientists understand more precisely how the release of acetylcholine is changing brain cell activity to influence memory and cognition.

15 Nov 2013

Veterinary News and Research

AccentHealth buys Caervision's Asthma and Allergy waiting room television network

PET imaging of brain reveals ketamine may act as antidepressant by regulating serotonin activity

Aratana Therapeutics announces acquisition of Okapi Sciences NV

Neogen acquires the stock of Chem-Tech

Viewpoints: Impact of 'meddling with' health law; antibiotics on farms; 'Let thirtysomethings' join Medicare

Researchers receive Doris Duke Foundation award to predict sickle cell crisis, monitor treatments

Researchers produce first definitive evidence that MERS-CoV infects camels

Pregnant women, infants should avoid unpasteurized milk products, urge pediatricians

Climate change may lead to decline in snail fever

Researchers discover completely new targets for treatment of blood cancers

Researchers discover easy-to-use method for bonding gels and biological tissues

Research: Creuztfeldt-Jakob disease might be transmitted by blood transfusion

Study reveals pathogenic factor that triggers prion and neurodegenerative diseases

MAXIMUS Foundation Chairman wins 2013 Ripple of Hope Award for contributions in health care programs

New genetics promises to change faulty genes of future generations by using "designer sperm”

Research: Modification of SUMO protein plays vital role in normal brain function

Rapid DNA biochip tests for screening disease-causing bacteria

UCP1 protein helps fight against obesity

Manipulating PRH protein can help prevent cancer cells from unnecessary migration

Research could refine next generation of drugs to help treat dementia

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News